Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma

被引:32
作者
Rosiñol, L
Carrió, A
Bladé, J
Queralt, R
Aymerich, M
Cibeira, MT
Esteve, J
Rozman, M
Campo, E
Montserrat, E
机构
[1] Univ Barcelona, IDIBAPS, Dept Hematol, Inst Hematol & Oncol,Hosp Clin Barcelona, E-08036 Barcelona, Spain
[2] Univ Barcelona, IDIBAPS, Haematopathol Dept, Hosp Clin Barcelona, E-08036 Barcelona, Spain
关键词
smoldering multiple myeloma; comparative genomic hybridisation; multiple myeloma; prognosis; transformation;
D O I
10.1111/j.1365-2141.2005.05673.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two variants of smoldering multiple myeloma (SMM) have been recognised: (i) an evolving type, characterised by a progressive increase in the M-protein size and short time to progression to overt multiple myeloma (MM) and (ii) a non-evolving type, with a long-lasting, stable M-protein and longer time to progression. Comparative genomic hybridisation (CGH) analyses in both subtypes of SMM (seven evolving and eight non-evolving SMM) were performed. Evolving SMM showed cytogenetic changes consistent with those found in de novo symptomatic MM (1q gains, chromosome 13 deletions) while the non-evolving variant showed no 1q gains and deletions were uncommon.
引用
收藏
页码:729 / 732
页数:4
相关论文
共 13 条
[1]  
AvetLoiseau H, 1997, GENE CHROMOSOME CANC, V19, P124, DOI 10.1002/(SICI)1098-2264(199706)19:2<124::AID-GCC8>3.0.CO
[2]  
2-0
[3]   Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization [J].
Cigudosa, JC ;
Rao, PH ;
Calasanz, MJ ;
Odero, MD ;
Michaeli, J ;
Jhanwar, SC ;
Chaganti, RSK .
BLOOD, 1998, 91 (08) :3007-3010
[4]   Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma [J].
Debes-Marun, CS ;
Dewald, GW ;
Bryant, S ;
Picken, E ;
Santana-Dávila, R ;
González-Paz, N ;
Winkler, JM ;
Kyle, RA ;
Gertz, MA ;
Witzig, TE ;
Dispenzieri, A ;
Lacy, MQ ;
Rajkumar, SV ;
Lust, JA ;
Greipp, PR ;
Fonseca, R .
LEUKEMIA, 2003, 17 (02) :427-436
[5]   Genomic abnormalities in monoclonal gammopathy of undetermined significance [J].
Fonseca, R ;
Bailey, RJ ;
Ahmann, GJ ;
Rajkumar, SV ;
Hoyer, JD ;
Lust, JA ;
Kyle, RA ;
Gertz, MA ;
Greipp, PR ;
Dewald, GW .
BLOOD, 2002, 100 (04) :1417-1424
[6]  
Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876
[7]   Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma [J].
Gutiérrez, NC ;
García, JL ;
Hernández, JM ;
Lumbreras, E ;
Castellanos, M ;
Rasillo, A ;
Mateo, G ;
Hernández, JM ;
Pérez, S ;
Orfao, A ;
San Miguel, JF .
BLOOD, 2004, 104 (09) :2661-2666
[8]   Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization [J].
Gutiérrez, NC ;
Hernández, JM ;
García, JL ;
Cañizo, MC ;
González, M ;
Hernández, J ;
González, MB ;
García-Marcos, MA ;
San Miguel, JF .
LEUKEMIA, 2001, 15 (05) :840-845
[9]   SMOLDERING MULTIPLE-MYELOMA [J].
KYLE, RA ;
GREIPP, PR .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (24) :1347-1349
[10]   Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma [J].
Liebisch, P ;
Viardot, A ;
Bassermann, N ;
Wendl, C ;
Roth, K ;
Goldschmidt, H ;
Einsele, H ;
Straka, C ;
Stilgenbauer, S ;
Döhner, H ;
Bentz, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (02) :193-201